東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

The Spectrum, Impact, and Management...

Abdel-Qadir, Husam-Eldin Mohamed.

FindBook

Google Book

Amazon

博客來

The Spectrum, Impact, and Management of Cardiovascular Disease in Ontario Women with Early Stage Breast Cancer.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	The Spectrum, Impact, and Management of Cardiovascular Disease in Ontario Women with Early Stage Breast Cancer./
作者:	Abdel-Qadir, Husam-Eldin Mohamed.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2018,
面頁冊數:	305 p.
附註:	Source: Dissertations Abstracts International, Volume: 80-02, Section: B.
Contained By:	Dissertations Abstracts International80-02B.
標題:	Medicine. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10689962
ISBN:	9780438186828

The Spectrum, Impact, and Management of Cardiovascular Disease in Ontario Women with Early Stage Breast Cancer.
Abdel-Qadir, Husam-Eldin Mohamed.

The Spectrum, Impact, and Management of Cardiovascular Disease in Ontario Women with Early Stage Breast Cancer. - Ann Arbor : ProQuest Dissertations & Theses, 2018 - 305 p.

Source: Dissertations Abstracts International, Volume: 80-02, Section: B.

Thesis (Ph.D.)--University of Toronto (Canada), 2018.

This item must not be sold to any third party vendors.

Background: There are limited data about the epidemiology of cardiovascular disease after early stage breast cancer. Methods: We conducted four cohort studies utilizing data from Ontario women diagnosed with early stage breast cancer between 1998 and 2015. The first study describes causes of death after breast cancer, with a focus on patient strata where death from cardiovascular causes may exceed that from breast cancer. The second study examines hospital presentations for different categories of cardiovascular disease, and their temporal relationship to heart failure, comparing early stage breast cancer cases to age-matched women without cancer. The third study develops a score for predicting cardiovascular risk after early stage breast cancer. The final study examines 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor (also known as statins) use after early stage breast cancer as a marker of cardiovascular preventative therapy, with comparison to cancer-free women of similar cardiovascular risk. Results: Breast cancer was the most common cause of death. Among patients with prior cardiovascular disease, the risks of death from breast cancer and cardiovascular disease were equivalent for the first five years, after which death from cardiovascular causes was more frequent. For women aged ≥66 years who survived ≥5 years after diagnosis, cardiovascular disease exceeded breast cancer as the leading cause of death at ten years post-diagnosis. The 10-year cumulative incidence of cardiovascular hospitalization was 11.7% after early stage breast cancer and 10.6% in controls. The ratio of cardiovascular disease rates between the cohorts increased with time. 76% of cardiovascular hospitalizations were for diagnoses other than heart failure. 36% of first heart failure presentations were preceded by hospital presentation with another cardiovascular disease. We developed a score to predict the risk of death or hospitalization from cardiovascular disease. Model calibration and discrimination were good. The c-index in the validation cohort was 81.3% at 5 years. Finally, we observed that women with early stage breast cancer were less likely to dispense statins compared to cancer-free women, though the differences were small. Relevance: These data provide useful insights into the importance of cardiovascular disease and how its management can be improved in women with early stage breast cancer.

ISBN: 9780438186828Subjects--Topical Terms:

641104
Medicine.

The Spectrum, Impact, and Management of Cardiovascular Disease in Ontario Women with Early Stage Breast Cancer.
LDR:03569nmm a2200325 4500 001 2210272
005 20191121124156.5
008 201008s2018 ||||||||||||||||| ||eng d
020 $a 9780438186828
035 $a (MiAaPQ)AAI10689962
035 $a (MiAaPQ)toronto:17052
035 $a AAI10689962
040 $a MiAaPQ $c MiAaPQ
100 1 $a Abdel-Qadir, Husam-Eldin Mohamed. $3 3437416
245 1 4 $a The Spectrum, Impact, and Management of Cardiovascular Disease in Ontario Women with Early Stage Breast Cancer.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2018
300 $a 305 p.
500 $a Source: Dissertations Abstracts International, Volume: 80-02, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Anderson, Geoffrey M.
502 $a Thesis (Ph.D.)--University of Toronto (Canada), 2018.
506 $a This item must not be sold to any third party vendors.
520 $a Background: There are limited data about the epidemiology of cardiovascular disease after early stage breast cancer. Methods: We conducted four cohort studies utilizing data from Ontario women diagnosed with early stage breast cancer between 1998 and 2015. The first study describes causes of death after breast cancer, with a focus on patient strata where death from cardiovascular causes may exceed that from breast cancer. The second study examines hospital presentations for different categories of cardiovascular disease, and their temporal relationship to heart failure, comparing early stage breast cancer cases to age-matched women without cancer. The third study develops a score for predicting cardiovascular risk after early stage breast cancer. The final study examines 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor (also known as statins) use after early stage breast cancer as a marker of cardiovascular preventative therapy, with comparison to cancer-free women of similar cardiovascular risk. Results: Breast cancer was the most common cause of death. Among patients with prior cardiovascular disease, the risks of death from breast cancer and cardiovascular disease were equivalent for the first five years, after which death from cardiovascular causes was more frequent. For women aged ≥66 years who survived ≥5 years after diagnosis, cardiovascular disease exceeded breast cancer as the leading cause of death at ten years post-diagnosis. The 10-year cumulative incidence of cardiovascular hospitalization was 11.7% after early stage breast cancer and 10.6% in controls. The ratio of cardiovascular disease rates between the cohorts increased with time. 76% of cardiovascular hospitalizations were for diagnoses other than heart failure. 36% of first heart failure presentations were preceded by hospital presentation with another cardiovascular disease. We developed a score to predict the risk of death or hospitalization from cardiovascular disease. Model calibration and discrimination were good. The c-index in the validation cohort was 81.3% at 5 years. Finally, we observed that women with early stage breast cancer were less likely to dispense statins compared to cancer-free women, though the differences were small. Relevance: These data provide useful insights into the importance of cardiovascular disease and how its management can be improved in women with early stage breast cancer.
590 $a School code: 0779.
650 4 $a Medicine. $3 641104
650 4 $a Epidemiology. $3 568544
690 $a 0564
690 $a 0766
710 2 $a University of Toronto (Canada). $b Health Policy, Management and Evaluation. $3 2105918
773 0 $t Dissertations Abstracts International $g 80-02B.
790 $a 0779
791 $a Ph.D.
792 $a 2018
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10689962